ACB
Aurora Cannabis Inc. Healthcare - Cannabis Investor Relations →
Aurora Cannabis Inc. (ACB) closed at $3.26 as of 2026-03-20, trading 50.9% below its 200-week moving average of $6.65. This places ACB in the extreme value zone. The stock is currently moving closer to the line, down from -49.4% last week. With a 14-week RSI of 17, ACB is in oversold territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.52 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 561 weeks of data, ACB has crossed below its 200-week moving average 2 times. On average, these episodes lasted 198 weeks. Historically, investors who bought ACB at the start of these episodes saw an average one-year return of +73.8%.
With a market cap of $185 million, ACB is a small-cap stock. The company generates a free cash flow yield of 6.4%, which is healthy. Return on equity stands at -15.5%. The stock trades at 0.5x book value.
Share count has increased 183.9% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 10.8 years, a hypothetical investment of $100 in ACB would have grown to $12, compared to $379 for the S&P 500. ACB has returned -17.9% annualized vs 13.1% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ACB vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ACB Crosses Below the Line?
Across 2 historical episodes, buying ACB when it crossed below its 200-week moving average produced an average return of -24.5% after 12 months (median +42.0%), compared to +7.0% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +256.5% vs +39.5% for the index.
Each line shows $100 invested at the moment ACB crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ACB has crossed below its 200-week MA 2 times with an average 1-year return of +73.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2015 | Aug 2016 | 58 | 63.0% | +73.8% | -86.6% |
| Oct 2019 | Ongoing | 337+ | 96.1% | Ongoing | -99.3% |
| Average | 198 | — | +73.8% | — |
Frequently Asked Questions
Is ACB below its 200-week moving average?
Yes. As of 2026-03-20, Aurora Cannabis Inc. (ACB) is trading 50.9% below its 200-week moving average of $6.65. The current price is $3.26.
What is ACB's 200-week moving average price?
Aurora Cannabis Inc.'s 200-week moving average is $6.65 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ACB drops below its 200-week moving average?
ACB has crossed below its 200-week moving average 2 times in our data. On average, buying at that moment produced a one-year return of +73.8%. These dips have historically been decent entry points. These episodes lasted 198 weeks on average.
Is ACB a good value right now?
Here's what our data says about ACB as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 17 (oversold). Free cash flow yield is 6.4%. Return on equity is -15.5%. Price-to-book is 0.5x. This is not a buy or sell recommendation — always do your own research.
How does ACB compare to the S&P 500?
Over the past 10.8 years, $100 invested in ACB would have grown to $12, compared to $379 for the S&P 500. That's -17.9% annualized vs 13.1% for the index. ACB has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20